{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T06:19:23Z","timestamp":1773123563961,"version":"3.50.1"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Soft tissue and other extraosseous sarcomas (STOES) are rare malignancies originating from mesenchymal tissues, posing a substantial health burden due to their aggressiveness and complex treatment. Understanding the global, regional, and national burden of STOES is crucial for effective prevention, screening, treatment, and resource allocation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using the standardized Global Burden of Disease (GBD) methodology, we calculated STOES incidence, prevalence, mortality, and disability-adjusted life years (DALYs) to derive the burden of disease caused by STOES. Results were presented in numerical counts and age-standardized rates per 100,000 population, with an uncertainty interval (UI) to highlight potential statistical variability. The Joinpoint regression analysis was used to analyze the time trend from 1990 to 2021. The method facilitates the calculation of annual percentage change (APC) and average annual percentage change (AAPC) and their corresponding 95% confidence intervals (CI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In 2021, the global burden of STOES remained substantial with 96,201 incident cases (ASIR: 1.16 per 100,000), 480,473 prevalent cases, 50,203 deaths (ASMR: 0.6 per 100,000), and 1,677,891 DALYs. Males had higher incidence, prevalence, mortality, and DALY rates than females. Regional disparities were evident, with high-income regions exhibiting higher incidence and prevalence but lower mortality rates compared to low-income regions. Notably, East Asia and Oceania had the lowest incidence rates, while Eastern Sub-Saharan Africa had the highest mortality and DALY rates. A mild downward trend was observed in incidence and prevalence, with more pronounced declines in mortality and DALY rates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Despite declining trends, the global burden of STOES remains significant, with notable regional differences. Tailored prevention, early detection, and treatment strategies, along with targeted resource allocation, are crucial. Further research is needed to understand the underlying factors driving these trends and develop effective interventions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0342986","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T17:26:56Z","timestamp":1773077216000},"page":"e0342986","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Global, regional, and national burden of soft tissue and other extraosseous sarcomas, 1990\u20132021: A Systematic analysis for the global burden of disease study 2021"],"prefix":"10.1371","volume":"21","author":[{"given":"Xingyue","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhong","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0616-4893","authenticated-orcid":true,"given":"Ruibo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"issue":"13","key":"pone.0342986.ref001","doi-asserted-by":"crossref","first-page":"1122508","DOI":"10.3389\/fonc.2023.1122508","article-title":"Targeted therapies for the treatment of soft tissue sarcoma","volume":"9","author":"JW Fuchs","year":"2023","journal-title":"Frontiers in Oncology"},{"issue":"11","key":"pone.0342986.ref002","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1089\/jwh.2023.0019","article-title":"Sex differences in soft tissue sarcoma: incidence, clinicopathological profile, survival, and costs","volume":"32","author":"A Buja","year":"2023","journal-title":"J Womens Health (Larchmt)"},{"issue":"8","key":"pone.0342986.ref003","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020294","article-title":"Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing","volume":"6","author":"F Ducimeti\u00e8re","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"pone.0342986.ref004","doi-asserted-by":"crossref","first-page":"46","DOI":"10.21037\/cco.2018.08.06","article-title":"Soft tissue sarcoma in Asia","volume":"7","author":"E Poon","year":"2018","journal-title":"Chin Clin Oncol"},{"issue":"6","key":"pone.0342986.ref005","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/pbc.23252","article-title":"Soft tissue sarcoma across the age spectrum: a population-based study from the Surveillance Epidemiology and End Results database","volume":"57","author":"A Ferrari","year":"2011","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"pone.0342986.ref006","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.canep.2015.03.002","article-title":"Burden of soft-tissue and bone sarcoma in routine care: Estimation of incidence, prevalence and survival for health services research","volume":"39","author":"F Trautmann","year":"2015","journal-title":"Cancer Epidemiol"},{"issue":"10","key":"pone.0342986.ref007","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/cac2.12197","article-title":"Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020","volume":"41","author":"H Qiu","year":"2021","journal-title":"Cancer Commun (Lond)"},{"issue":"1","key":"pone.0342986.ref008","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1470-2045(21)00581-7","article-title":"The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"23","author":"Collaborators GBD 2019 Adolescent Young Adult Cancer","year":"2022","journal-title":"Lancet Oncol"},{"issue":"10","key":"pone.0342986.ref009","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1038\/s41591-022-01990-1","article-title":"The global burden of disease study at 30 years","volume":"28","author":"C Murray","year":"2022","journal-title":"Nat Med"},{"issue":"10440","key":"pone.0342986.ref010","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"issue":"10258","key":"pone.0342986.ref011","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"issue":"10440","key":"pone.0342986.ref012","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","article-title":"Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"issue":"16","key":"pone.0342986.ref013","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1002\/sim.9407","article-title":"Twenty years since Joinpoint 1.0: Two major enhancements, their justification, and impact","volume":"41","author":"H-J Kim","year":"2022","journal-title":"Stat Med"},{"issue":"11","key":"pone.0342986.ref014","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S2352-4642(22)00219-X","article-title":"Global, regional, and national burdens of HIV and other sexually transmitted infections in adolescents and young adults aged 10-24 years from 1990 to 2019: a trend analysis based on the Global Burden of Disease Study 2019","volume":"6","author":"J Zhang","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"key":"pone.0342986.ref015","doi-asserted-by":"crossref","first-page":"102619","DOI":"10.1016\/j.eclinm.2024.102619","article-title":"Global, regional, and national burden of thalassemia, 1990-2021: a systematic analysis for the global burden of disease study 2021","volume":"72","author":"Y Tuo","year":"2024","journal-title":"EClinicalMedicine"},{"key":"pone.0342986.ref016","doi-asserted-by":"crossref","first-page":"5467057","DOI":"10.1155\/2018\/5467057","article-title":"Treatment Patterns and Survival among Adult Patients with Advanced Soft Tissue Sarcoma: A Retrospective Medical Record Review in the United Kingdom, Spain, Germany, and France","volume":"2018","author":"SP Nagar","year":"2018","journal-title":"Sarcoma"},{"issue":"4","key":"pone.0342986.ref017","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1001\/jamaoncol.2016.5688","article-title":"Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study","volume":"3","author":"C Fitzmaurice","year":"2017","journal-title":"JAMA Oncol"},{"issue":"9","key":"pone.0342986.ref018","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1002\/ijc.34409","article-title":"Incidence and survival of soft tissue sarcoma in England between 2013 and 2017, an analysis from the National Cancer Registration and Analysis Service","volume":"152","author":"A Bacon","year":"2023","journal-title":"Int J Cancer"},{"key":"pone.0342986.ref019","doi-asserted-by":"crossref","first-page":"111822","DOI":"10.1016\/j.envres.2021.111822","article-title":"Occupational pesticide exposure, cancer and chronic neurological disorders: A systematic review of epidemiological studies in greenspace workers","volume":"203","author":"L de Graaf","year":"2022","journal-title":"Environ Res"},{"issue":"11","key":"pone.0342986.ref020","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1002\/ijc.33936","article-title":"Agricultural exposure and risk of soft tissue sarcomas and gastrointestinal stromal sarcoma in the AGRIculture and CANcer (AGRICAN) cohort","volume":"150","author":"M Renier","year":"2022","journal-title":"Int J Cancer"},{"key":"pone.0342986.ref021","doi-asserted-by":"crossref","first-page":"101596","DOI":"10.1016\/j.canep.2019.101596","article-title":"Incidence, mortality, and survival trends of soft tissue and bone sarcoma in Switzerland between 1996 and 2015","volume":"63","author":"A Koll\u00e1r","year":"2019","journal-title":"Cancer Epidemiol"},{"issue":"1","key":"pone.0342986.ref022","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s12889-018-5131-4","article-title":"Strengthening health data on a rare and heterogeneous disease: sarcoma incidence and histological subtypes in Germany","volume":"18","author":"M Ressing","year":"2018","journal-title":"BMC Public Health"},{"issue":"1","key":"pone.0342986.ref023","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s13643-021-01769-4","article-title":"Association between occupational exposures and sarcoma incidence and mortality: systematic review and meta-analysis","volume":"10","author":"D Edwards","year":"2021","journal-title":"Syst Rev"},{"issue":"4","key":"pone.0342986.ref024","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jviscsurg.2015.05.001","article-title":"Soft tissue sarcoma in France in 2015: Epidemiology, classification and organization of clinical care","volume":"152","author":"C Honor\u00e9","year":"2015","journal-title":"J Visc Surg"},{"key":"pone.0342986.ref025","unstructured":"United Nations. High-level meeting on prevention and control of non-communicable diseases. 2011. (accessed 17\/7 2024). http:\/\/www.un.org\/en\/ga\/ncdmeeting2011\/"},{"key":"pone.0342986.ref026","unstructured":"World Health Organization. Preventing Noncommunicable Diseases (NCDs) by Reducing Environmental Risk Factors. 2017. (accessed 17\/7 2024). https:\/\/www.who.int\/publications\/i\/item\/WHO-FWC-EPE-17.01"},{"key":"pone.0342986.ref027","article-title":"Soft-tissue sarcoma in Japan: National cancer registry-based analysis from 2016 to 2019","volume":"7","author":"K Ogura","year":"2024","journal-title":"Jpn J Clin Oncol"},{"issue":"20","key":"pone.0342986.ref028","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1002\/cncr.32367","article-title":"Soft-tissue sarcoma in adolescents and young adults compared with older adults: A report among 5000 patients from the Scandinavian Sarcoma Group Central Register","volume":"125","author":"KE Papworth","year":"2019","journal-title":"Cancer"},{"issue":"1","key":"pone.0342986.ref029","first-page":"67","article-title":"Soft Tissue Sarcoma of Extremities: Descriptive Epidemiological Analysis According to National Population-based Study","volume":"10","author":"A Ebrahimpour","year":"2022","journal-title":"Arch Bone Jt Surg"},{"issue":"9","key":"pone.0342986.ref030","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.3109\/0284186X.2014.888494","article-title":"Prevalence and prognostic impact of comorbidity in soft tissue sarcoma: a population-based cohort study","volume":"53","author":"K Maretty-Nielsen","year":"2014","journal-title":"Acta Oncol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0342986","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T17:27:01Z","timestamp":1773077221000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0342986"}},"subtitle":[],"editor":[{"given":"Patricia","family":"Khashayar","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0342986","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]}}}